USG Awards Pharmaceutical Company Funds To Develop Ebola Treatment

The Hill: Feds award company up to $35M to develop Ebola drug
“The Department of Health and Human Services (HHS) on Tuesday awarded about $12 million to a North Carolina pharmaceutical company that has been developing Ebola treatments. The company, BioCryst Pharmaceuticals, has created a ‘promising’ experimental drug that prevents the Ebola virus from reproducing; it has been effective in preliminary studies, according to a release Tuesday…” (Ferris, 3/31).